How Pham was paid
$1.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Options | Other | Total |
|---|---|---|---|---|---|
| Quang X. PhamChief Executive Officer | $751,275 | $296,754 | $847,665 | $14,000 | $1,909,694 |
| Matthew SzotFormer Chief Financial Officer | $459,716 | $181,588 | $652,050 | $13,665 | $1,307,019 |
| James J. FergusonFormer Chief Medical Officer | $457,414 | $136,350 | $778,920 | $23,125 | $1,395,809 |
What changed and why
- $1.9M2025 CEO compensation totaled $1,909,694 versus $1,223,381 in 2024.
- $751K$751,275 CEO salary and $296,754 bonus were reported for 2025.
- $848K$847,665 in CEO option awards represented the largest component of his 2025 compensation.
- 50%50% was the CEO’s annual target bonus opportunity.
- $10,500$10,500 of Dr. Ferguson’s other compensation comprised consulting fees earned before his appointment.
- Matthew Szot and James Ferguson were identified as former executives after their 2025 service.
Other Cadrenal Therapeutics proxy statements
- 2025 proxy statement
Quang X. Pham paid $1.2M (+27% on the year).
Filed Jul 31, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.